Tag:
Saturn
Latest Headlines
Latest Headlines
AZ's Crestor scored points, but didn't beat Lipitor
AstraZeneca's press release on the SATURN trial is an object lesson in how to spin a study that didn't turn out as expected: Focus on the positive. The company announced SATURN showed "intensive"
AstraZeneca's Crestor fails to best Lipitor in study
AstraZeneca ( $AZN ) just lost a potential marketing edge for Crestor. In trial results announced today, the statin drug failed to best Lipitor at clearing clogged arteries, at least in a statistically
Crestor-Lipitor match-up results anticipated soon
It may be a case of wishful thinking, but Sanford Bernstein analyst Tim Anderson thinks AstraZeneca ( $AZN ) will soon unveil top-line results from its head-to-head trial pitting Crestor against
